UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
SNUH opens new Covid-19 treatment center in 2 days
Seoul National University Hospital (SNUH) said Thursday that it opened a la...
by Shim Hyun-tai
|
2020-08-27 18:06
라인
Genexine's cytokine drug effective on severe Covid-19 patients
Genexine said Thursday that it has confirmed the safety and efficacy of lon...
by Shim Hyun-tai
|
2020-08-27 18:05
라인
Korea publishes guidelines for digital therapeutics
The Ministry of Food and Drug Safety has published the guidelines for winni...
by Kim Yun-mi
|
2020-08-27 18:05
라인
Drugmakers to sue government for limiting choline alfoscerate benefit
Manufacturers of choline alfoscerate, a dementia drug, are reportedly prepa...
by Kim Yun-mi
|
2020-08-27 14:26
라인
Stocks of 3 Covid-19 vaccine developers spike
Three Korean drugmakers working on a Covid-19 vaccine have garnered robust ...
by Kim Chan-hyuk
|
2020-08-27 14:07
라인
New virus cases reach six-month high; tightest restrictions imminent
Korea reported new Covid-19 cases of more than 400 for the first time in si...
by Shim Hyun-tai
|
2020-08-27 13:24
라인
Helixmith’s antibody therapy shows efficacy in immunoglobulin kidney disease
A joint research team of Helixmith and Seoul National University College of...
by Shim Hyun-tai
|
2020-08-26 17:47
라인
Celltrion to begin P1 trial of antibody-drug on mild Covid-19 patients
Celltrion has begun recruiting mild Covid-19 patients for the Phase 1 clini...
by Shim Hyun-tai
|
2020-08-26 17:17
라인
‘Stringent social distancing can calm Covid-19 in early September’
The nation’s daily new cases of Covid-19 rebounded to exceed 300 on Wednesd...
by Song Soo-youn
|
2020-08-26 16:25
라인
Why medical school students give up pursuing public health jobs
A total of 2,811 seniors of the six-year medical colleges and the four-year...
by Song Soo-youn
|
2020-08-26 16:21
라인
HK inno.N, T&R Biofab to develop skin therapy using 3D tech
HK inno.N has teamed up with T&R Biofab to test the efficacy of its skin di...
by Shim Hyun-tai
|
2020-08-26 16:19
라인
Virus cases rebound above 300, pushing nation closer to tightest restrictions
Korea’s new Covid-19 cases climbed back above 300 Wednesday, stepping up pr...
by Shim Hyun-tai
|
2020-08-26 13:35
라인
Novartis fails trial on skin cancer drug candidate spartalizumab
Novartis said it its phase-3 trial on immunotherapy spartalizumab, a progra...
by Kim Yun-mi
|
2020-08-26 11:11
라인
CrystalGenomics’ anticancer candidate has FDA’s orphan drug status
CrystalGenomics said Monday that the U.S. Food and Drug Administration has ...
by Shim Hyun-tai
|
2020-08-25 17:07
라인
[Column] How ongoing doctors’ strike is different from 20 years ago
The recent series of strikes by physicians are different from those two dec...
by Park Jae-young Executive editor
|
2020-08-25 17:07
라인
PharmAbcine, Samsung Biologics sign CDMO deal for antibody candidate
PharmAbcine, a bio company specializing in antibody therapies, said Tuesday...
by Shim Hyun-tai
|
2020-08-25 16:57
라인
Huons' eye drop wins Saudi’s regulatory nod
Huons' flagship eye drop product entered the Saudi Arabia market, signa...
by Shim Hyun-tai
|
2020-08-25 14:50
라인
New virus cases below 300 for 2nd day but spreads continue
Korea saw new Covid-19 cases of below 300 for the second day on Tuesday but...
by Shim Hyun-tai
|
2020-08-25 11:51
라인
Drugmakers in active open innovation with startups
The local pharmaceutical industry is increasingly seeking “open innovation,...
by Kim Chan-hyuk
|
2020-08-25 11:51
라인
HK inno.N publishes P3 trial results of drug on gastric ulcers
HK inno.N has published the results of phase 3 clinical trial of gastroesop...
by Shim Hyun-tai
|
2020-08-24 18:02
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top